Table 4 Replication of suggestive index SNPs reported in recent GWAS of BPH.

From: Heritability and genome-wide association study of benign prostatic hyperplasia (BPH) in the eMERGE network

SNP

CHR:BP (hg19)

Gene

PMID

P-value

OR

EAab

OAac

eMERGE P-value

OR (95% CI)

eMERGE Effect Allele

rs6537704

1:112052105

ADORA3

28656603

1.1 × 10−5

1.34

G

A

0.17

1.08 (0.97–1.19)

T

rs10915971

1:226508645

PARP1

28656603

3.9 × 10−5

1.21

A

G

0.33

0.96 (0.88–1.04)

T

rs10202096

2:28596317

FOSL2

28656603

1.1 × 10−5

0.81

A

G

0.2

1.05 (0.97–1.13)

A

rs2556378

2:60762502

BCL11A

30410027

3.4 × 10−12

1.12

T

G

0.020

1.13(1.03-1.22)

T

rs12490648

3:27782163

EOMES

28656603

7.8 × 10−6

1.48

G

A

0.53

1.05 (0.89–1.22)

A

rs7630221

3:37192199

LRRFIP2

28656603

1.4 × 10−5

1.22

A

G

0.7

0.99 (0.92–1.06)

A

rs3922844

3:38624253

SCN5A

28656603

1.8 × 10−5

1.23

A

G

0.37

0.97 (0.89–1.04)

T

rs2853677

5:1287194

TERT

30410027

1.7 × 10−12

1.09

G

A

0.021

1.09 (1.02–1.17)

G

rs381949

5:1322468

CLPTM1L

30410027

4.9 × 10−19

0.9

A

G

0.033

0.92 (0.85–1.00)

A

rs2676245

5:13628062

DNAH5

28656603

7.3 × 10−6

0.81

A

G

0.95

1.00 (0.93–1.08)

A

rs10054105

5:110909333

STARD4

30410027

3.5 × 10−12

0.91

G

T

0.80

0.99 (0.90–1.08)

G

rs677394

5:134607559

C5orf66, H2AFY

30410027

2.9 × 10−11

0.88

G

C

0.50

0.96 (0.82–1.09)

G

rs200476

6:27768348

HIST1H2BL

30410027

3.9 × 10−17

0.88

T

A

0.076

0.92 (0.82–1.01)

T

rs17144046

10:8606014

GATA3

28656603

8.9 × 10−7

1.41

G

A

0.068

1.08 (1.00–1.16)

A

rs7906649

10:22310298

EBLN1

30410027

2.1 × 10−7

1.07

G

A

0.74

1.01 (0.93-1.10)

G

rs148678804

10:22427289

DNAJC1

30410027

3.0 × 10−14

1.27

A

G

0.52

0.91 (0.63–1.19)

A

rs7911634

10:56441151

PCDH15

28656603

1.5 × 10−5

0.67

A

C

0.87

1.01 (0.87–1.16)

T

rs4548546

10:122629579

WDR11

30410027

2.0 × 10−16

1.11

T

C

0.099

1.07 (0.99–1.14)

T

rs11199879

10:123045212

FGFR2

30410027

5.7 × 10−23

1.14

C

T

0.0065

1.13 (1.04–1.21)

C

rs72878024

11:199492

ODF3

30410027

1.4 × 10−12

0.85

A

G

0.43

0.94 (0.79–1.09)

A

rs428215

11:37126189

RAG2

28656603

4.2 × 10−5

0.76

G

A

0.8

0.98 (0.87–1.10)

T

rs10894022

11:129191124

BARX2

28656603

2.6 × 10−5

0.79

A

G

0.48

0.97 (0.87–1.06)

T

rs11613206

12:40609581

LRRK2

28656603

4.9 × 10−5

1.15

A

G

0.81

0.98 (0.81–1.15)

A

rs6538357

12:93150937

PLEKHG7

28656603

4.9 × 10−5

0.84

C

A

0.61

0.98 (0.91–1.05)

A

rs2555019

12:114668618

TBX5

30410027

2.4 × 10−11

0.93

T

C

0.66

0.98 (0.91–1.06)

T

rs8853

12:115108907

TBX3

30410027

1.4 × 10−9

1.07

C

T

0.47

1.03 (0.95–1.10)

C

rs1638703

13:51088356

DLEU1

30410027

1.1 × 10−13

1.1

C

G

0.19

1.06 (0.98–1.14)

C

rs6561599

13:51478918

RNASEH2B

30410027

1.8 × 10−7

0.94

C

G

0.26

0.96 (0.89–1.03)

C

rs9302078

13:96171939

CLDN10

28656603

3.0 × 10−5

0.83

A

G

0.67

1.02 (0.94–1.09)

A

rs7152796

14:89924520

FOXN3

28656603

4.0 × 10−5

1.46

A

G

0.94

0.99 (0.84–1.15)

T

rs943587

14:97636701

VRK1

28656603

0.80

1.11

G

A

0.96

1.00 (0.91–1.10)

A

rs11651052

17:36102381

HNF1B

30410027

3.2 × 10−10

0.93

A

G

0.77

0.99 (0.92–1.06)

A

rs9958656

18:19904144

GATA6

30410027

4.3 × 10−19

1.11

T

C

0.031

1.08 (1.01–1.16)

T

rs17670370

18:20034017

CTAGE1

30410027

1.6 × 10−7

1.07

G

T

0.31

0.96 (0.87–1.04)

G

rs11084596

19:32104979

THEG5

30410027

2.1 × 10−24

0.88

C

T

0.33

1.04 (0.96–1.12)

C

rs6061244

20:61041653

GATA5

30410027

5.7 × 10−8

0.94

C

G

0.27

0.96 (0.88–1.03)

C

rs200383755

20:61050522

GATA5

30410027

3.2 × 10−9

0.67

C

G

NA

NA

NA

  1. aNa et al. (PMID 28656603) contained no indication for which was the modeled effect allele. For the purpose of this table, their A1 is listed as EA, and A2 is under OA. bEffect Allele. cOther Allele.